August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Yüksel Ürün: The terms ‘manageable’ and ‘acceptable’ can be misleading
Jul 28, 2024, 06:21

Yüksel Ürün: The terms ‘manageable’ and ‘acceptable’ can be misleading

Yüksel Ürün shared a post by Yakup Ergün, Medical Oncologist at Antalya City Hospital, on X, adding:

The terms ‘manageable’ and ‘acceptable’ safety profiles can be misleading. Adverse events and treatment interruptions can significantly impact patients’ quality of life. It’s essential to reconsider these terms to ensure they truly represent patient experiences.

Quoting Yakup Ergün’s post:

“Can we truly label a study with Grade 5 toxicity as ‘acceptable’ or ‘manageable’? My letter on the necessity of “redefining toxicity terminology in clinical trial reporting” (original title).”

Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial

Yüksel Ürün

Source: Yüksel Ürün/X and Yakup Ergün/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field